Regulation of glial cyclooxygenase by bradykinin

Peptides

Volumn 28, Issue 4, 2007, Pages 845-850

  Levy, Einat ^a   Fleisher Berkovich, Sigal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bradykinin; Cyclooxygenase; Glial cells; Prostaglandin E2

Indexed keywords

BRADYKININ; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; PARACETAMOL; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GLIA CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRADYKININ; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; NEUROGLIA; RATS; RATS, WISTAR;

RATTUS;

EID: 33847388446     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.01.013     Document Type: Article

References (32)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. Amann R., Schuligoi R., and Peskar B.A. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. Inflamm Res 50 (2001) 50-53
3. Aronoff D.M., Oates J.A., and Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Therap 79 (2006) 9-19
4. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243 (1997) 726-731
5. Hall J.M. Bradykinin receptors. Gen Pharmacol 28 (1997) 1-6
6. in t' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. New Engl J Med 345 (2001) 1515-1521
7. Hemler M.E., and Lands W.E. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 255 (1980) 6253-6261
8. Ho L., Pieroni C., Winger D., Purohit D.P., Aisen P.S., and Pasinetti G.M. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res 57 (1999) 295-303
9. Hsieh H.L., Wu C.Y., Hwang T.L., Yen M.H., Parker P., and Yang C.M. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-KB in astrocytes. Cell Signalling 19 (2007) 330-340
10. 2 by the activation of cyclooxygenase-2. Neurosci Lett 401 (2006) 242-247
11. Jong Y.J., Ford S.R., Seehra K., Malave V.B., and Baenziger N.L. Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation. FASEB J 17 (2003) 2319-2321
12. Koyama Y., and Baba A. Endothelin-induced protein tyrosine phosphorylation of cultured astrocytes: its relationship to cytoskeletal actin organization. Glia (1999) 324-332
13. Levant A., Levy E., Argaman M., and Fleisher-Berkovich S. Kinins and neuroinflammation: dual effect on prostaglandin synthesis. Eur J Pharmacol 546 (2006) 197-200
14. 2 in human fibroblasts. J Biol Chem 267 (1992) 23451-23454
15. Lowry O.H., Rosebrough A.L., Randal R.J., and Farr A.L. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
16. Luo J., Lang J.A., and Miller M.W. Transforming growth factor beta 1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons. J Neurochem 71 (1998) 526-534
17. McGeer P.L., Rogers J., and McGeer E.G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimer's Dis 9 (2006) 271-276
18. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3 (2004) 845-852
19. Matoth I., Pinto F., Sicsic C., and Brenner T. Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neurosci Res 38 (2000) 209-212
20. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63 (2004) 901-910
21. 2 levels in patients with probable AD. Neurology 53 (1999) 1495-1498
22. Oldenburg O., Qin Q., Krieg T., Yang X.M., Philipp S., Critz S.D., et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circul Physiol 286 (2004) 468-476
23. Otto J.C., and Smith W.L. Prostaglandin endoperoxide synthase-1 and -2. J Lipid Mediat 12 (1995) 139-156
24. 2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am J Physiol Lung Cell Mol Physiol 273 (1997) L1132-L1140
25. Rodriguez J.A., De la Cerda P., Collyer E., Decap V., Vio C.P., and Velarde V. Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290 (2006) H30-H36
26. Rosenstock M., Danon A., and Rimon G. Prostaglandin H synthase: protein synthesis-independent regulation in bovine aortic endothelial cells. Am J Physiol 273 (1997) 1749-1755
27. Rosenstock M., Danon A., Rubin M., and Rimon G. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs. Eur J Pharmacol 412 (2001) 101-108
28. Swinney D.C., Mak A.Y., Barnett J., and Ramesha C.S. Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. J Biol Chem 272 (1997) 12393-12398
29. 2α production, cyclooxygenase, and cell growth by a pertussis toxin sensitive mechanism. J Cell Physiol 163 (1995) 285-294
30. Yang M.S., Ji K.A., Jeon S.B., Jin B.K., Kim I.J., and Joe E. Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia. J Immunol 177 (2006) 1323-1329
31. Yermakova A.V., Rollins J., Callahan L.M., Rogers J., and O'Banion M.K. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Exp Neurol 58 (1999) 1135-1146
32. Yermakova A.V., and O'Banion M.K. Down regulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease. Neurobiol Aging 22 (2001) 823-836